JNJ
Johnson & Johnson (JNJ)
Last Price$165.9(1.1%)
Market Cap$398.7B
LTM Enterprise Value
$364.6B
5Y avg
$415.0B
Drug Manufacturers - General industry median
$178.5B
Stock quality & Intrinsic value
6/10
0.2% undervalued

Johnson & Johnson Enterprise Value

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Enterprise Value
$166.6B
$180.0B
$192.0B
$162.3B
$174.9B
$159.6B
$166.4B
$190.1B
$250.4B
$274.7B
$265.5B
$298.4B
$394.1B
$358.6B
$395.2B
$421.3B
$452.7B
$459.6B
$383.7B
$364.6B
JNJ
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for JNJ and see if it's the right time to invest.
Dive in

Johnson & Johnson (JNJ) Enterprise Value comparison analysis

JNJ key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Jan'06Dec'06Dec'07Dec'08Jan'10Jan'11Jan'12Dec'12Dec'13Dec'14Jan'16Jan'17Dec'17Dec'18Dec'19Jan'21Jan'22Jan'23Dec'23Dec'24
% growth
50,514.0
6.7%
53,324.0
5.6%
61,095.0
14.6%
63,747.0
4.3%
61,897.0
(2.9%)
61,587.0
(0.5%)
65,030.0
5.6%
67,224.0
3.4%
71,312.0
6.1%
74,331.0
4.2%
70,074.0
(5.7%)
71,890.0
2.6%
76,450.0
6.3%
81,581.0
6.7%
82,059.0
0.6%
82,584.0
0.6%
78,740.0
(4.7%)
79,990.0
1.6%
85,159.0
6.5%
88,821.0
4.3%
Cost of Goods Sold (COGS)14,010.015,057.017,751.018,511.018,447.018,792.020,360.021,658.022,342.022,746.021,536.021,789.025,439.027,091.027,556.028,427.023,402.024,596.026,553.027,471.0
% margin
36,504.0
72.3%
38,267.0
71.8%
43,344.0
70.9%
45,236.0
71.0%
43,450.0
70.2%
42,795.0
69.5%
44,670.0
68.7%
45,566.0
67.8%
48,970.0
68.7%
51,585.0
69.4%
48,538.0
69.3%
50,101.0
69.7%
51,011.0
66.7%
54,490.0
66.8%
54,503.0
66.4%
54,157.0
65.6%
55,338.0
70.3%
55,394.0
69.3%
58,606.0
68.8%
61,350.0
69.1%
Operating Expenses23,673.024,558.028,131.029,067.026,787.026,268.028,517.028,534.030,013.030,448.030,249.029,210.032,114.033,315.033,533.034,424.034,395.034,381.035,197.039,201.0
Research & Development Expenses (R&D)6,462.07,125.07,680.07,577.06,986.06,844.07,548.07,665.08,183.08,494.09,046.09,143.010,594.010,775.011,355.012,340.014,277.014,135.015,085.017,232.0
Selling, General & Administrative Expenses (SG&A)17,211.017,433.020,451.021,490.019,801.019,424.020,969.020,869.021,830.021,954.021,203.020,067.021,520.022,540.022,178.022,084.020,118.020,246.020,112.021,969.0
12,831.0
25.4%
13,709.0
25.7%
15,213.0
24.9%
16,169.0
25.4%
16,663.0
26.9%
16,527.0
26.8%
16,153.0
24.8%
17,032.0
25.3%
18,957.0
26.6%
21,137.0
28.4%
18,289.0
26.1%
20,891.0
29.1%
18,897.0
24.7%
21,175.0
26.0%
20,970.0
25.6%
19,733.0
23.9%
20,943.0
26.6%
21,013.0
26.3%
23,409.0
27.5%
22,149.0
24.9%
Interest Income0.00.0452.0361.090.0107.091.064.074.067.0128.0368.0385.0611.0357.0111.053.0490.01,261.01,332.0
Interest Expense0.00.0296.0435.0451.0455.0571.0532.0482.0533.0552.0726.0934.01,005.0318.0201.0183.0276.0772.0755.0
Pre-tax Income13,116.014,587.013,283.016,929.015,755.016,947.012,361.013,775.015,471.020,563.019,196.019,803.017,673.017,999.017,328.016,497.019,178.019,359.015,062.016,687.0
% effective tax rate
3,056.0
23.3%
3,534.0
24.2%
2,707.0
20.4%
3,980.0
23.5%
3,489.0
22.1%
3,613.0
21.3%
2,689.0
21.8%
3,261.0
23.7%
1,640.0
10.6%
4,240.0
20.6%
3,787.0
19.7%
3,263.0
16.5%
16,373.0
92.6%
2,702.0
15.0%
2,209.0
12.7%
1,783.0
10.8%
1,377.0
7.2%
2,989.0
15.4%
1,736.0
11.5%
2,621.0
15.7%
% margin
10,060.0
19.9%
11,053.0
20.7%
10,576.0
17.3%
12,949.0
20.3%
12,266.0
19.8%
13,334.0
21.7%
9,672.0
14.9%
10,853.0
16.1%
13,831.0
19.4%
16,323.0
22.0%
15,409.0
22.0%
16,540.0
23.0%
1,300.0
1.7%
15,297.0
18.8%
15,119.0
18.4%
14,714.0
17.8%
20,878.0
26.5%
17,941.0
22.4%
35,153.0
41.3%
14,066.0
15.8%
EPS3.383.763.674.674.454.863.543.914.905.865.576.080.485.755.745.597.936.8313.885.84
Diluted EPS3.353.733.634.574.404.783.493.864.815.705.485.930.475.615.635.517.816.7313.725.79
% margin
14,924.0
29.5%
15,886.0
29.8%
16,356.0
26.8%
20,196.0
31.7%
18,980.0
30.7%
20,341.0
33.0%
16,090.0
24.7%
17,973.0
26.7%
20,057.0
28.1%
24,991.0
33.6%
23,494.0
33.5%
24,283.0
33.8%
24,249.0
31.7%
25,933.0
31.8%
24,655.0
30.0%
23,929.0
29.0%
26,751.0
34.0%
26,605.0
33.3%
23,320.0
27.4%
24,781.0
27.9%

Discover more Stock Ideas

FAQ

1) What is Johnson & Johnson's Enterprise Value?

As of today, Johnson & Johnson's last 12-month Enterprise Value is $364.6B, based on the financial report for Dec 27, 2024 (Q4’2024).

2) What is Johnson & Johnson's Enterprise Value growth rate?

Over the last year, Johnson & Johnson's Enterprise Value growth was (5.0%). The average annual Enterprise Value growth rates for Johnson & Johnson have been (7.0%) over the past three years, (1.6%) over the past five years.

3) Is Johnson & Johnson's Enterprise Value growth rate Good?

Over the last year, Johnson & Johnson's Enterprise Value growth was (5.0%), which is lower than industry growth of 0.0%. It indicates that Johnson & Johnson's Enterprise Value growth is Bad.

4) How does Johnson & Johnson's Enterprise Value growth rate compare to its peers?

Over the last year, Johnson & Johnson's Enterprise Value growth was (5.0%), which is lower than peer median growth of (0.5%). The list of peers includes LLY, ABBV, NVO, MRK, AZN, NVS, AMGN, PFE, GILD, SNY etc.